CRWV fell 11.4% on May 8 after its first-quarter earnings print. The stock closed at $114.15. That one-day drop came the same day a wave of analysts raised their price targets — making this one of the cleaner illustrations of a bull-bear split the AI infrastructure space has seen this week.
The analyst response to the results was almost uniformly constructive on targets, yet the ratings underneath tell a more divided story. Wells Fargo and Jefferies sit at Overweight and Buy respectively, with targets of $155 and $160. JP Morgan raised its target to $105 but kept a Neutral rating — the stock was already trading above that level post-drop, making JP Morgan effectively a near-term sideliners. Mizuho moved to $110, also Neutral. Truist lifted to $131 from $85 while staying at Hold. The consensus mean target is $137 — roughly 20% above Friday's close — but the mix of ratings behind that average reflects genuine disagreement. The bulls cite the $21 billion Meta contract and the Weights & Biases acquisition as proof of a differentiated AI infrastructure platform. Bears point to customer concentration and a CapEx structure that demands relentless growth: estimated capital expenditures run at roughly $33 billion on a forward basis against an enterprise value just under $105 billion.
The short interest picture adds texture. At 15.1% of free float, the position is meaningful — roughly 58 million shares short as of May 7. That's up about 2% on the week, a modest rebuild after a larger unwind that ran from mid-April highs near 66 million shares. The ORTEX short score has eased from 56.9 on April 24 to 54.1 now, suggesting the pressure is moderating rather than building. Availability in the lending market is loose — utilization has dropped sharply from nearly 29% in early April to around 14% — meaning there are plentiful shares to borrow for anyone still inclined to press the short. The cost to borrow is just 0.37% annualised, barely above zero. Nothing in the borrow market points to a squeeze setup at current levels.
Options positioning has also shifted after the earnings print. The put/call ratio edged up to 0.87 on May 8 — slightly above its 20-day mean of 0.85 — but the z-score of 0.58 is well within normal range. That contrasts with late March and early April, when the PCR ran consistently above 0.93. Options traders have actually become less defensive over the past six weeks, which makes the post-earnings price action look more like a mechanical reaction than a sustained repositioning.
The insider activity this week is worth flagging. Magnetar Financial — the top institutional holder with a 12% stake — sold over $60 million worth of stock on May 5, the day before the earnings release. The transactions covered multiple tranches at prices around $126–$129. Whether this was routine portfolio trimming or a pre-earnings risk reduction is unclear, but the timing and size stand out. Magnetar still holds roughly 65.5 million shares, so the position remains substantial.
The next confirmed earnings event is June 8. Between now and then, the divergence between analyst target upgrades and the stock trading well below several of those revised targets is the core tension worth tracking.
See the live data behind this article on ORTEX.
Open CRWV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
